Concepedia

Umesh Chaudhari

UC

Statistics

Publications

35

Citations

6K

H-Index

28

Active since

2001

Affiliations

University of Cologne(Current)

Regeneron (United States)

Sanofi (France)

Sanofi (United States)

Leibniz Research Centre for Working Environment and Human Factors

Umesh Chaudhari is an author at University of Cologne specializing in pharmacology, medicine, and pharmacotherapy.

ORCID

Publications per year

2001–2024

35

Publications

35

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Jennifer G. Robinson, Michel Farnier, Michel Krempf et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

, , +17

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Umesh Chaudhari, Pat Romano, LD Mulcahy et al. · The Lancet · 2001 · 904 citations

, , +11

Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

Christopher P. Cannon, Bertrand Cariou, Dirk Blom et al. · European Heart Journal · 2015 · 399 citations · Full text

, , +17

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon et al. · American Heart Journal · 2015 · 347 citations · Full text

, , +17

Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab

Jennifer G. Robinson, Robert S. Rosenson, Michel Farnier et al. · Journal of the American College of Cardiology · 2017 · 195 citations · Full text

, , +17

1–5 of 35